@Article{Wlaźlak2002,
journal="Menopause Review/Przegląd Menopauzalny",
issn="1643-8876",
volume="1",
number="4",
year="2002",
title="Clinical efficacy and tolerance of oral low-dose continuous estrogen-progestin therapy (Activelle)",
abstract="New therapeutical option for hrt \– oral low-dose continuous estrogen-progestin therapy with the use of 1 mg estradiol and 0.5 mg norethisterone acetate was evaluated in the article. We find Activelle (Novo Nordisk) effective in the treatment of menopausal symptoms. This drug is well tolerated by postmenopausal women. The frequency of side effects is low. The most common is spotting/bleeding: 22.6% patients in the first month of hrt, 6.9% treated women after 6 months.",
author="Wlaźlak, Edyta
and Surkont, Grzegorz
and Suzin, Jacek",
pages="35--38",
url="https://www.termedia.pl/Clinical-efficacy-and-tolerance-of-oral-low-dose-continuous-estrogen-progestin-therapy-Activelle-,4,2011,1,1.html"
}